egtazic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, A; Arya, P; Bansal, SK; Bhatia, S; Chatterjee, S; Chaudhury, NK; DePass, AL; Dhawan, A; Gangopadhyay, S; Joshi, R; Kumar, A; Manral, S; Parmar, VS; Prasad, AK; Raj, HG; Rohil, V; Saso, L; Sinha, R; Sreedhara, SC; Vijayan, VK | 1 |
1 other study(ies) available for egtazic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM.
Topics: Calcium; Calcium Channel Blockers; Cell Line; Cells, Cultured; Chelating Agents; Egtazic Acid; Female; Flow Cytometry; Humans; Intracellular Space; Lymphocytes; Male; Microscopy, Fluorescence; Middle Aged; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Kinase C; Pulmonary Disease, Chronic Obstructive; Pyrimidinones; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smoking | 2011 |